Effects of endothelin-receptor antagonism with PD156707 on myocardial stunning in swine

Journal of Cardiovascular Pharmacology
T B McClanahanK P Gallagher

Abstract

Endothelin (ET) has been proposed to play a role in pathogenesis of myocardial ischemia/reperfusion injury. The potential role of ET in myocardial stunning has not been examined. Therefore we tested the hypothesis that selective blockade of ETA receptors with PD156707 {sodium 2-benzo[1,3]dioxol-5-yl-4-(4-methoxy-phenyl) -4-oxo-3-(3,4,5-trimethoxy-benzyl)-but-2-enoate} could improve postischemic contractile dysfunction in open-chest pigs. Myocardial stunning was achieved by a sequence of three 10-min left anterior descending (LAD) occlusions interspersed with 15 min of reperfusion. All pigs received either an intravenous saline vehicle (n =6) or PD156707 (n = 6) at a loading dose infusion of 10 mg/kg/h for 1 h before the first occlusion followed by a maintenance dose of 7 mg/kg/h for 4 h. Systolic wall thickening (percentage of baseline) was measured with sonomicrometers. There was no significant difference in systolic thickening between groups at baseline, at the end of the final stunning occlusion, or at any of the time points during reperfusion. PD156707 significantly reduced arterial blood pressure before myocardial ischemia and throughout reperfusion. There was no significant difference in size of the region at risk between...Continue Reading

References

Oct 1, 1992·Journal of Cardiovascular Pharmacology·F J RicouK L Peterson
Jul 31, 1992·Biochemical and Biophysical Research Communications·M ClozelR Osterwalder
Nov 1, 1992·Journal of Molecular and Cellular Cardiology·F BrunnerL H Opie
Jul 1, 1991·Journal of the American College of Cardiology·D J StewartP Cernacek
Jan 18, 1990·The New England Journal of Medicine·C J Murray
Apr 1, 1990·Circulation Research·R J SchottW Schaper
Aug 1, 1990·Circulation·G C LiB R Lucchesi
Jan 1, 1989·Journal of Cardiovascular Pharmacology·J PernowJ M Lundberg
Feb 28, 1989·Biochemical and Biophysical Research Communications·C S MoravecM Bond
Aug 11, 1985·The American Journal of Physiology·K P GallagherJ Ross
Dec 1, 1982·Circulation·E Braunwald, R A Kloner
Aug 1, 1994·Cardiovascular Drugs and Therapy·D HasdaiA Battler
Jan 1, 1995·Cardiovascular Research·A A Wilde, G Aksnes
Apr 1, 1994·Circulation·C M WeiJ C Burnett
Aug 1, 1993·Cardiovascular Research·T TønnessenG Christensen
Mar 1, 1996·Journal of Molecular and Cellular Cardiology·P WangM V Cohen

❮ Previous
Next ❯

Citations

Jul 5, 2005·Expert Opinion on Investigational Drugs·J J Maguire, A P Davenport
Dec 1, 2001·The Journal of Thoracic and Cardiovascular Surgery·A T GoodwinM H Yacoub

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.